Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
290 Leser
Artikel bewerten:
(1)

Neurovo: Harmony Neurocare Opens Castle Rock Clinic, Bringing Life-Changing TMS Therapy to Colorado

New mental health treatment center offers FDA-approved breakthrough for depression when traditional treatments fall short

CASTLE ROCK, COLORADO / ACCESS Newswire / October 15, 2025 / Harmony Neurocare, a mental health treatment center specializing in Transcranial Magnetic Stimulation (TMS) therapy, has officially opened its doors in Castle Rock, Colorado. The clinic offers hope to individuals struggling with treatment-resistant depression, OCD, and other mental health conditions through cutting-edge, non-invasive brain stimulation technology.

Harmony Neurocare

Harmony Neurocare

TMS therapy uses targeted magnetic pulses to gently reawaken areas of the brain that influence mood, thought patterns, and emotional wellbeing. Unlike medications that treat symptoms, TMS addresses the neurological source of depression, helping stimulate specific brain regions responsible for healthy function. The treatment boasts close to 80% improvement rate, with 50% of patients achieving full remission-some of the highest success rates in mental health care.

"For too long, people have suffered in silence, cycling through treatments that offer only temporary relief," said Rosana, Founder of Harmony Neurocare. "Harmony Neurocare was founded with a singular mission: to make TMS accessible to all those who need it. This isn't just about opening a clinic-it's about creating a sanctuary where healing is possible, where hope is restored, and where no one has to carry the weight of their struggle alone."

The Castle Rock location serves as Harmony Neurocare's flagship clinic, featuring on-site board-certified psychiatrists who provide comprehensive assessments and personalized treatment planning. Each patient receives individualized care, from initial consultation through treatment completion and optional maintenance sessions.

At the heart of Harmony Neurocare's mission is a deeply personal story. The company's namesake, Harmony, battled relentless depression for years, exhausting traditional treatments before finding life-changing relief through TMS therapy. Her journey from darkness to renewed hope inspired the creation of a practice dedicated to compassionate, purpose-driven care.

"We understand what it means to feel misunderstood, to carry stigma, to wonder if healing is even possible," Rosana added. "Every person who walks through our doors is met with that understanding. We're not just treating a condition-we're restoring lives."

The Castle Rock clinic offers flexible scheduling to accommodate busy lifestyles, with treatment sessions lasting just 10-30 minutes. Patients are cared for during the session by our team, can read or watch TV, and return immediately to daily activities afterward. Most insurance plans provide full or partial coverage for TMS therapy, and Harmony Neurocare works directly with providers to verify benefits and ensure transparent pricing.

For patients who face financial barriers, Harmony Neurocare offers Harmony Scholarships-a program designed to make treatment available to individuals who don't qualify for insurance coverage or cannot afford care on their own.

TMS therapy is FDA-approved, safe, and non-invasive, with no memory loss, personality changes, or long-term side effects. It's particularly effective for individuals who haven't responded to traditional antidepressants or therapy alone, and can be used alongside existing treatments.

Harmony Neurocare is now accepting new patients at its Castle Rock location. To schedule a no-pressure consultation or learn more about TMS therapy, visit harmonyneurocare.com or call 303-409-7446

About Harmony Neurocare
Harmony Neurocare is a mental health treatment center specializing in Transcranial Magnetic Stimulation (TMS) therapy for depression, anxious-depression, late-life depression, OCD, and other conditions. Founded on principles of compassion, accessibility, and evidence-based care, Harmony Neurocare is dedicated to helping individuals reclaim their lives when traditional treatments haven't worked.

Contact Information

Rosana Graves
Founder
rosana@harmonyneurocare.com
303-409-7446

.

SOURCE: Neurovo



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/harmony-neurocare-opens-castle-rock-clinic-bringing-life-changing-tms-1086917

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.